Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local bupivacaine with or without dexamethasone for acute post-cesarean pain
IRCT20220501054713N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and dexamethasone in acute postoperative pain (3 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Pain intensity at recovery admission. Started May 2022; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on IRCT20220501054713N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220501054713N1.